Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) - Phase 2 Study of MLN0128 (TAK-228) in Patients with Tumors with TSC1 or TSC2 Mutations: Sub-protocol EAY131-M

J. Hays, Z. Song, P. Paik, G. Iyer, E. Mitchell, J. Wright, L. Doyle, R. Gray, V. Wang, L. McShane, L. Rubinstein, D. Patton, M. Williams, S. Hamilton, B. Conley, C. Arteaga, L. Harris, P. O'Dwyer, A. Chen, K. Flaherty

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)S25
JournalEuropean Journal of Cancer
StatePublished - Oct 2022
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this